Aptinyx Reports Third Quarter 2019 Financial Results and Highlights

Ads

You May Also Like

TESARO Announces First-Quarter 2018 Operating Results

ZEJULA Q1 net sales totaled $49 millionEnrollment completed in Phase 3 PRIMA first-line ovarian ...

FIT Biotech Oy: EHVA clinical trial authorization granted for testing FIT-06 in UK

FIT Biotech Oy                                                             Company release 26.6.2018 at 8:30 AM EET EHVA clinical trial authorization ...